Moderna
MRNA
#1356
Rank
A$23.43 B
Marketcap
A$59.97
Share price
-0.82%
Change (1 day)
2.01%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$23.43 Billion

As of February 2026 Moderna has a market cap of A$23.43 Billion. This makes Moderna the world's 1356th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$23.43 B28.74%
2025A$18.20 B-26.69%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Moderna was reported to be:

A$23.42 Billion
by Nasdaq info icon info icon
A$23.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$798.04 B 3,305.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$408.60 B 1,643.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$411.15 B 1,654.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.80 B-96.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.23 B-81.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.18 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$66.04 B 181.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$14.35 B-38.74%๐Ÿ‡บ๐Ÿ‡ธ USA